SAB Biotherapeutics, Inc. - SABS Net Assets per Single Share

Graphic logo of SAB Biotherapeutics (SABS)

SAB Biotherapeutics (SABS) minimizes outsourcing risks through long-term agreements with contract research organizations. The business possesses high macro-resilience, as drug development remains independent of economic cycles. Historical book value per share valuations on GURU.Markets contain data where 2.56 serves as the final level marker. Management relies on an innovative antibody creation platform, focusing on the therapy of infectious diseases.

SAB Biotherapeutics Inc. (SABS): Share Book Value from 07/04/2022 to 10/28/2026

sabbiotherapeutics.com - analytical breakdowns and key metrics (SABS)

- price and consensus price forecast:
Stock Price SAB Biotherapeutics, Inc|SABS - Price Target Chart
- market capitalization data:
Market Value SAB Biotherapeutics, Inc.|SABS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share SAB Biotherapeutics|SABS - Net Asset Value|Market Capitalization to Book Value Ratio sabbiotherapeutics.com|SABS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital SAB Biotherapeutics|SABS - Long-Term Debt to Capital|Short-Term Debt to Equity SAB Biotherapeutics, Inc.|SABS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio SAB Biotherapeutics, Inc.
Fundamental company valuation:SAB Biotherapeutics, Inc - SABS
Manufactured products of SAB Biotherapeutics, Inc.

SAB Biotherapeutics' unique human antibody creation platform establishes a capital barrier that is reflected in the dynamics of the stock's estimated book value. This indicator determines the share of net assets per share after deducting all liabilities, allowing investors to compare the real value of the company's tangible resources with market quotes to assess the fundamental overvaluation or undervaluation of the asset.

Competitors of SAB Biotherapeutics (SABS)

ARGX - Book Value per Share|BNTX: Net Assets per Single Share|Abivax Corp - Net Assets per Single Share|ADMA (admabiologics.com) - Net Assets per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|AnaptysBio Inc - Net Asset Value per Share|Net Assets per Single Share ATXS (Astria Pharma)|ENGN - Net Assets per Share|RAPT: Book Value per Share|Aerovate Therapeutics (JBIO) - Book Value per Share|Book Value per Share Aclaris Therapeutics, Inc.|Net Assets per Single Share Kyverna Therapeutics Inc. (KYTX)|Tiziana Life Sciences PLC (TLSA) - Accounting Value per Share|Accounting Value of a Share Cabaletta Bio Inc (CABA)|Book Value per Share Ventyx Biosciences VTYX|Net Assets per Single Share theratech.com THTX|Book Value per Share AVTX (Avalo Therapeutics)|ELDN: Net Assets per Share|Net Assets per Single Share AGEN|Net Asset Value per Share Climb Bio, Inc|Zura Bio Limited (ZURA) - Accounting Value per Share|Book Price of a Share atyrpharma.com|Adagene (ADAG) - Book Value per Share|Accounting Value of a Share ikenaoncology.com (IMA)|STTK: Book Value per Share|Equillium Inc - Net Asset Value per Share|Net Assets per Single Share Connect Pharma (CNTB)|IMUX - Accounting Value of a Share|ATRA: Book Value per Share|IFRX (InflaRx) - Book Value per Share|Net Assets per Single Share X4 Pharma XFOR|Share Book Value Adicet|Celularity Inc. - Book Value per Share|Net Asset Value per Share inmunebio.com INMB|Accounting Value per Share BRNS (Barinthus Biotherapeutics plc)|KZR - Book Value per Share|Accounting Value per Share Akari Therapeutics plc AKTX|ENLV - Book Price of a Share|q32bio.com - Book Value per Share|geovax.com (GOVX) - Net Assets per Share|Book Value per Share EDSA|Accounting Value per Share IBIO|CARM (Carisma Therapeutics) - Net Assets per Single Share|Net Assets per Share XTLB (XTL Bio)|Net Assets per Single Share BOLT|Net Assets per Share HCW Biologics, Inc. HCWB|Aptevo - Book Value per Share|AIM - Book Value per Share|aditxt.com (ADTX) - Book Value per Share|GRI (GRI Bio Corporation) - Net Assets per Single Share|XRTX: Net Assets per Single Share|Net Assets per Share HIND|REVB - Net Assets per Single Share|Share Book Value Indaptus Therapeutics Inc (INDP)|Book Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|ALLK: Book Value per Share|Net Assets per Single Share hookipapharma.com HOOK|IGMS (IGM Biosciences) - Accounting Value of a Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share thirdharmonicbio.com THRD